EUCRU
Eucrates Biomedical Acquisition Corp. Unit (EUCRU)
$00
About Eucrates Biomedical Acquisition Corp. Unit (EUCRU)
Eucrates Biomedical Acquisition Corp. operates as a blank Check company focusing on acquiring, engaging in a share exchange, share reconstruction and amalgamations. The company was founded by Stelios Papadopoulos, Parag Saxena, Evangelos Vergetis and Daphne Karydas on August 21, 2020 and is headquartered in New York, NY.
Details
Daily high
$10.02
Daily low
$10.01
Price at open
$10.01
52 Week High
$10.66
52 Week Low
$9.76
Market cap
42.1M
Dividend yield
0.00%
Volume
21,513
Avg. volume
1,441
P/E ratio
53.35
Eucrates Biomedical Acquisition Corp. Unit News
Details
Daily high
$10.02
Daily low
$10.01
Price at open
$10.01
52 Week High
$10.66
52 Week Low
$9.76
Market cap
42.1M
Dividend yield
0.00%
Volume
21,513
Avg. volume
1,441
P/E ratio
53.35